LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Monday reported a loss of $11.3 million in its first quarter.
The Lexington, Massachusetts-based company said it had a loss of 20 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.
The gene therapy company posted revenue of $19.5 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $10.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a VYGR">Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR